Remus Pharmaceuticals Statistics
Total Valuation
NSE:REMUS has a market cap or net worth of INR 8.04 billion. The enterprise value is 8.30 billion.
| Market Cap | 8.04B |
| Enterprise Value | 8.30B |
Important Dates
The last earnings date was Monday, November 10, 2025.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | Nov 14, 2025 |
Share Statistics
NSE:REMUS has 11.66 million shares outstanding. The number of shares has increased by 3.88% in one year.
| Current Share Class | 11.66M |
| Shares Outstanding | 11.66M |
| Shares Change (YoY) | +3.88% |
| Shares Change (QoQ) | -18.98% |
| Owned by Insiders (%) | 69.50% |
| Owned by Institutions (%) | n/a |
| Float | 3.45M |
Valuation Ratios
The trailing PE ratio is 25.21.
| PE Ratio | 25.21 |
| Forward PE | n/a |
| PS Ratio | 1.08 |
| PB Ratio | 2.38 |
| P/TBV Ratio | 2.70 |
| P/FCF Ratio | 359.11 |
| P/OCF Ratio | 118.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.15, with an EV/FCF ratio of 370.74.
| EV / Earnings | 24.78 |
| EV / Sales | 1.11 |
| EV / EBITDA | 16.15 |
| EV / EBIT | 16.96 |
| EV / FCF | 370.74 |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.61 |
| Quick Ratio | 0.86 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.31 |
| Debt / FCF | 7.15 |
| Interest Coverage | 37.97 |
Financial Efficiency
Return on equity (ROE) is 18.30% and return on invested capital (ROIC) is 12.30%.
| Return on Equity (ROE) | 18.30% |
| Return on Assets (ROA) | 7.75% |
| Return on Invested Capital (ROIC) | 12.30% |
| Return on Capital Employed (ROCE) | 13.12% |
| Revenue Per Employee | 109.99M |
| Profits Per Employee | 4.93M |
| Employee Count | 68 |
| Asset Turnover | 1.89 |
| Inventory Turnover | 9.08 |
Taxes
In the past 12 months, NSE:REMUS has paid 110.90 million in taxes.
| Income Tax | 110.90M |
| Effective Tax Rate | 20.83% |
Stock Price Statistics
The stock price has decreased by -47.08% in the last 52 weeks. The beta is 0.17, so NSE:REMUS's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -47.08% |
| 50-Day Moving Average | 728.48 |
| 200-Day Moving Average | 907.29 |
| Relative Strength Index (RSI) | 42.25 |
| Average Volume (20 Days) | 4,435 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:REMUS had revenue of INR 7.48 billion and earned 335.10 million in profits. Earnings per share was 27.37.
| Revenue | 7.48B |
| Gross Profit | 969.10M |
| Operating Income | 489.80M |
| Pretax Income | 532.50M |
| Net Income | 335.10M |
| EBITDA | 507.50M |
| EBIT | 489.80M |
| Earnings Per Share (EPS) | 27.37 |
Balance Sheet
The company has 209.40 million in cash and 160.10 million in debt, giving a net cash position of 49.30 million or 4.23 per share.
| Cash & Cash Equivalents | 209.40M |
| Total Debt | 160.10M |
| Net Cash | 49.30M |
| Net Cash Per Share | 4.23 |
| Equity (Book Value) | 3.38B |
| Book Value Per Share | 321.55 |
| Working Capital | 1.18B |
Cash Flow
In the last 12 months, operating cash flow was 67.80 million and capital expenditures -45.40 million, giving a free cash flow of 22.40 million.
| Operating Cash Flow | 67.80M |
| Capital Expenditures | -45.40M |
| Free Cash Flow | 22.40M |
| FCF Per Share | 1.92 |
Margins
Gross margin is 12.96%, with operating and profit margins of 6.55% and 4.48%.
| Gross Margin | 12.96% |
| Operating Margin | 6.55% |
| Pretax Margin | 7.12% |
| Profit Margin | 4.48% |
| EBITDA Margin | 6.79% |
| EBIT Margin | 6.55% |
| FCF Margin | 0.30% |
Dividends & Yields
This stock pays an annual dividend of 0.75, which amounts to a dividend yield of 0.11%.
| Dividend Per Share | 0.75 |
| Dividend Yield | 0.11% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 1.76% |
| Buyback Yield | -3.88% |
| Shareholder Yield | -3.77% |
| Earnings Yield | 4.17% |
| FCF Yield | 0.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 4, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Jul 4, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |